FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine. The composition contains, wt %: 1-phenyl-2,3-dimethyl-4-iodopyrazolone-5 - 5.0-10.0; oxygenated dextrane - 40.0-45.0; polyethylene glycol - 20.0-45.0; phosphatidylcholine - 10.0-30.0.
EFFECT: use of the declared composition enables higher clinical effectiveness in tick-borne encephalitis.
1 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL TUBERCULOSIS COMPOSITION | 2008 |
|
RU2372914C1 |
ANTIVIRAL PREPARATION | 2001 |
|
RU2190402C1 |
AGENT "IODANTIPIRIN" FOR PROPHYLAXIS AND TREATMENT OF PATIENTS WITH TICK-BORNE ENCEPHALITIS | 1997 |
|
RU2141826C1 |
MEANS FOR FORMATION OF MEDICINE FOR CURING TICK-BORNE ENCEPHALITIS | 2016 |
|
RU2651777C1 |
PHARMACEUTICAL COMPOSITION FOR TREATING BURNS | 2012 |
|
RU2473349C1 |
WOUND-HEALING MEANS | 2017 |
|
RU2644255C1 |
PHARMACEUTICAL COMPOSITION FOR INFLUENZA PREVENTION | 2014 |
|
RU2572332C1 |
PHARMACEUTICAL COMPOSITION FOR TREATING FUNGOID DISEASES | 2010 |
|
RU2430730C1 |
PHARMACEUTICAL COMPOSITION FOR TREATING CYTOSTATIC MYELOSUPPRESSION | 2012 |
|
RU2471490C1 |
COMPOSITION FOR TREATING BURNS | 2014 |
|
RU2559087C1 |
Authors
Dates
2013-01-20—Published
2012-02-02—Filed